NFJ Investment Group’s Edwards Lifesciences EW Stock Holding History

NFJ Investment Group’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$33.7K	Buy	421 +39	+10%	+$3.21K	﹤0.01%	196
2025 Q4	$32.6K	Hold	382	–	–	﹤0.01%	195
2025 Q3	$29.7K	Hold	382	–	–	﹤0.01%	226
2025 Q2	$29.9K	Hold	382	–	–	﹤0.01%	251
2025 Q1	$27.7K	Hold	382	–	–	﹤0.01%	271
2024 Q4	$28.3K	Sell	382 -22,816	-98%	-$1.6M	﹤0.01%	262
2024 Q3	$1.53M	Sell	23,198 -460,132	-95%	-$33.4M	0.04%	235
2024 Q2	$44.6M	Sell	483,330 -63,487	-12%	-$5.62M	1.37%	13
2024 Q1	$52.3M	Sell	546,817 -49,600	-8%	-$4.17M	1.43%	13
2023 Q4	$45.5M	Buy	596,417 +36,766	+7%	+$2.56M	1.26%	23
2023 Q3	$38.8M	Buy	559,651 +419,332	+299%	+$33.7M	1.13%	29
2023 Q2	$13.2M	Sell	140,319 -37,638	-21%	-$3.27M	0.35%	85
2023 Q1	$14.7M	Buy	+177,957	New	+$14M	0.39%	75
2021 Q4	–	Sell	-39,879	Closed	-$4.51M	–	367
2021 Q3	$4.51M	Sell	39,879 -1,033	-3%	-$118K	0.09%	230
2021 Q2	$4.24M	Sell	40,912 -4,189	-9%	-$395K	0.08%	249
2021 Q1	$3.77M	Buy	+45,101	New	+$3.81M	0.08%	261

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

NFJ Investment Group's EW Position: Q1 2026 in Review

NFJ Investment Group increased its Edwards Lifesciences (EW) stake by 10% in Q1 2026, buying an estimated $3.21K and bringing the position to 421 shares worth $33.7K. The position accounts for ﹤0.01% of the portfolio, ranked #196.

NFJ Investment Group first reported a position in EW in Q1 2021 and has held it in 16 quarters since. The position peaked at $52.3M in Q1 2024. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

NFJ Investment Group held 421 shares of Edwards Lifesciences worth $33.7K as of Q1 2026.
NFJ Investment Group bought 39 Edwards Lifesciences shares in Q1 2026, an estimated $3.21K.
Edwards Lifesciences made up ﹤0.01% of NFJ Investment Group's portfolio in Q1 2026, its #196 holding.
NFJ Investment Group first reported a position in Edwards Lifesciences in Q1 2021 and has held it in 16 quarters since.
NFJ Investment Group's Edwards Lifesciences position peaked at $52.3M in Q1 2024.
1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on NFJ Investment Group's 13F filing for Q1 2026, filed 13 May 2026.